Date Filed | Type | Description |
10/03/2023 |
4
| Johnson Robert Matthew (President & CEO) has filed a Form 4 on SILICON LABORATORIES INC.
Txns:
| Sold 3,534 shares
@ $115.23, valued at
$407.2k
|
|
10/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/03/2023 |
4
| Johnson Robert Matthew (President & CEO) has filed a Form 4 on SILICON LABORATORIES INC.
Txns:
| Sold 3,498 shares
@ $144.06, valued at
$503.9k
|
|
08/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/26/2023 |
10-Q
| Quarterly Report for the period ended July 1, 2023 |
07/26/2023 |
8-K
| Quarterly results |
07/03/2023 |
8-K
| Credit agreement amendment
Docs:
|
"FIFTH AMENDMENT TO CREDIT AGREEMENT THIS FIFTH AMENDMENT TO CREDIT AGREEMENT , dated as of June 30, 2023, is by and among Silicon Laboratories Inc., a Delaware corporation , the Lenders party hereto and WELLS FARGO BANK, NATIONAL ASSOCIATION, as administrative agent . Capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed thereto in the Credit Agreement. W I T N E S S E T H WHEREAS, the Borrower, certain banks and financial institutions from time to time party thereto and Bank of America, N.A., as the original administrative agent, are parties to that certain Credit Agreement dated as of July 31, 2012 ; WHEREAS, pursuant to that certain Agency Resignation, Assignment and Acceptance Agreement, dated as of July 24, 2015, by and among Bank of America, ..." |
|
05/26/2023 |
SD
| Form SD - Specialized disclosure report: |
05/16/2023 |
4
| Hollister John C (Sr VP and CFO) has filed a Form 4 on SILICON LABORATORIES INC.
Txns:
| Paid exercise price by delivering 1,829 shares
@ $136.32, valued at
$249.3k
Granted 6,397 shares
@ $0 |
|
05/16/2023 |
4
| Johnson Robert Matthew (President & CEO) has filed a Form 4 on SILICON LABORATORIES INC.
Txns:
| Paid exercise price by delivering 3,537 shares
@ $136.32, valued at
$482.2k
Granted 15,992 shares
@ $0 |
|
05/16/2023 |
4
| Kumar Sandeep P (Sr VP, Worldwide Operations) has filed a Form 4 on SILICON LABORATORIES INC.
Txns:
| Paid exercise price by delivering 1,029 shares
@ $136.32, valued at
$140.3k
Granted 3,199 shares
@ $0 |
|
05/16/2023 |
4
| MAULDIN MARK D (Chief Accounting Officer) has filed a Form 4 on SILICON LABORATORIES INC.
Txns:
| Paid exercise price by delivering 451 shares
@ $136.32, valued at
$61.5k
Granted 3,199 shares
@ $0 |
|
05/16/2023 |
4
| Tolany Brandon (Sr VP of Worldwide Sales) has filed a Form 4 on SILICON LABORATORIES INC.
Txns:
| Paid exercise price by delivering 1,563 shares
@ $136.32, valued at
$213.1k
Granted 4,798 shares
@ $0 |
|
05/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/26/2023 |
10-Q
| Quarterly Report for the period ended April 1, 2023 |
04/26/2023 |
8-K
| Quarterly results |
04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/21/2023 |
8-K
| Quarterly results |
04/21/2023 |
8-K
| Quarterly results |
04/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
04/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
03/22/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
03/10/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 10.2% stake in Silicon Laboratories Inc. |
03/08/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
03/08/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
|